‘An important milestone:’ Canada approves expensive new drug that can slow Alzheimer’s disease CTV NewsNew treatment gives hope to patients with early Alzheimer’s disease CBCHealth Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease CityNews HalifaxHealth Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease The SpecHealth Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease Newswire Canada
